Replies to post #93597 on Biotech Values

[DewDiligence]

Wall Street’s expectations are low for MON’s FY2Q10 earnings report tomorrow, as far as I can tell. It seems that many analysts expect not only a bad quarter, but also a reduction in the FY2010 EPS guidance.